ProjectKlinische Studien – BRF117019
Basic data
Acronym:
Klinische Studien
Title:
BRF117019
Duration:
13/11/2014 to 12/11/2016
Abstract / short description:
Open-label, Study in Patients with BRAF V600E-Mutated Rare Cancers with Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib.
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Research training group: Intraoperative multi-sensor tissue identification in oncology
Research training groups
Research training groups
Local organizational units
General and Molecular Pathology and Pathological Anatomy
Institute of Pathology and Neuropathology (Department)
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Funders
München, Bayern, Germany